About this trial
The aim of the study is to establish an infectious risk stratification system based on pre-and post-operative blood endotoxin profile.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults that is able to consent (≥ 18 years of age)
Scheduled to undergo PCNL at Uhealth tower and Jackson Memorial Hospitals
not currently immunosuppressed [White blood count (WBC) >= 2, not on immunosuppressive medications]
Disqualifiers
unable to consent and < 18 years of age
currently immunosuppressed (WBC < 2, not on immunosuppressive medications)
Trial population
Patients scheduled for PCNL as surgical treatment for their kidney stones at Jackson and the University of Miami Hospitals.
Trial design
Case-only
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Number of participants at each endotoxin activity level after surgery.
The endotoxin activity level assessed from blood samples will be categorized as low (\<0.40), intermediate (0.40-0.59) or high (≥0.60) endotoxin activity level. Analysis will be done via Endotoxin Activity Assay (EAA).
Corelation of endotoxin activity level with post-operative infectious complication
infectious complications include fever, and signs and symptoms of systemic inflammatory response syndrome as evaluated by treating physician.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.